Long pages

Showing below up to 50 results in range #1 to #50.

1. (hist) ‎32. Cell signalling, receptors and kinases ‎[27,581 bytes]
2. (hist) ‎10. Pharmacokinetics: zero and first order elimination kinetics, elimination half-life, volume of distribution, clearance, maintenance dose, loading dose, oral bioavailability ‎[20,801 bytes]
3. (hist) ‎0. Oogenesis and the menstrual cycle ‎[19,964 bytes]
4. (hist) ‎Heart failure ‎[19,557 bytes]
5. (hist) ‎7. Distribution of drugs ‎[17,254 bytes]
6. (hist) ‎Test characteristics ‎[16,464 bytes]
7. (hist) ‎8. Biotransformation of drugs ‎[16,352 bytes]
8. (hist) ‎38. Antineoplastic drugs: Cytotoxic drugs ‎[16,302 bytes]
9. (hist) ‎39. Antineoplastic drugs: Biological therapy ‎[16,105 bytes]
10. (hist) ‎29. Regulation of gene expression ‎[16,053 bytes]
11. (hist) ‎86. Drug intoxications. Mechanisms, symptoms, treatment ‎[16,031 bytes]
12. (hist) ‎13. Development of the female genital organs. Malformations ‎[16,007 bytes]
13. (hist) ‎11. Formation and derivatives of the heart tube. Partitioning of the cardiac chambers. Malformations ‎[15,654 bytes]
14. (hist) ‎82. Pharmacogenetics, pharmacogenomics. Effects of age, diet and disease on drug action ‎[15,587 bytes]
15. (hist) ‎9. The intestinal tube and its derivatives (with the exception of the pharyngeal gut). Malformations ‎[15,502 bytes]
16. (hist) ‎43. Inflammatory, tumorous diseases as well as disorders associated with hyperplasia of the thyroid gland (+ hyperthyroidism and hypothyroidism) ‎[15,284 bytes]
17. (hist) ‎Ovarian cancer ‎[15,210 bytes]
18. (hist) ‎21. RNA metabolism ‎[14,896 bytes]
19. (hist) ‎66. Insulin and oral hypoglycaemic agents. Glucagon ‎[14,820 bytes]
20. (hist) ‎2. Characterisation of agonist-receptor interaction. Occupancy, affinity, dose-response curve, potency, efficacy ‎[14,650 bytes]
21. (hist) ‎25. Water-soluble vitamins ‎[14,609 bytes]
22. (hist) ‎32. Nonneoplastic bone marrow disorders (anaemia, leukocytosis and leukopenia, thrombocytopenia) ‎[14,497 bytes]
23. (hist) ‎84. Drug interactions ‎[14,495 bytes]
24. (hist) ‎3. Neurochemistry of synapses, neurotransmitters, postsynaptic receptors and neuromodulators. EPSP, IPSP ‎[14,313 bytes]
25. (hist) ‎36. Non-steroidal antiinflammatory drugs. Aspirin, paracetamol ‎[14,269 bytes]
26. (hist) ‎Breast cancer ‎[14,102 bytes]
27. (hist) ‎Cardiac arrest ‎[13,928 bytes]
28. (hist) ‎Purpose of investigation ‎[13,853 bytes]
29. (hist) ‎6. Absorption of drugs ‎[13,568 bytes]
30. (hist) ‎5. Development of the blood vessels. Malformations ‎[13,515 bytes]
31. (hist) ‎85. The treatment of the intoxicated patient: decontamination, facilitation of toxicant elimination, antidote administration, supportive treatment ‎[13,457 bytes]
32. (hist) ‎2. Biochemistry of digestion ‎[13,365 bytes]
33. (hist) ‎37. AIDS. Transplantation immunity ‎[13,314 bytes]
34. (hist) ‎24. Protein synthesis 1. Participants and mechanism ‎[13,302 bytes]
35. (hist) ‎9. Excretion of drugs ‎[13,236 bytes]
36. (hist) ‎Acute abdomen ‎[13,133 bytes]
37. (hist) ‎41. Principles and evaluation of respiratory function tests. Characteristics and parameters of abnormal breathing mechanics ‎[13,127 bytes]
38. (hist) ‎56. Congenital heart diseases ‎[12,790 bytes]
39. (hist) ‎Obesity ‎[12,740 bytes]
40. (hist) ‎4. Mechanisms of drug antagonisms ‎[12,709 bytes]
41. (hist) ‎50. Antidepressants ‎[12,672 bytes]
42. (hist) ‎Testicular cancer ‎[12,570 bytes]
43. (hist) ‎Enzymes and regulation ‎[12,536 bytes]
44. (hist) ‎25. Protein synthesis 2. Regulation, posttranslational modifications ‎[12,534 bytes]
45. (hist) ‎83. Harmful effects of drugs ‎[12,511 bytes]
46. (hist) ‎21. Regulation of H+ ion concentration in the blood ‎[12,388 bytes]
47. (hist) ‎58. Cysts and tumours of the ovaries (surface epithelial, germ cell, sex cordstromal tumours, tumours, metastases) ‎[12,337 bytes]
48. (hist) ‎18. Describe the two pathways involved in the initiation of blood coagulation ‎[12,330 bytes]
49. (hist) ‎6. Development of the face, formation of the nasal and oral cavities. Malformations ‎[12,325 bytes]
50. (hist) ‎47. Antianxiety and hypnotic drugs ‎[12,184 bytes]